The Lancet Regional Health Europe·2 OctChanging epidemiology and etiology of hepatocellular carcinoma in Europe: implications for clinical practice and health policyReviewHepatocellular carcinomaPaper
Journal of Hepatology·29 SepEASL-EASD-EASO Guidance for the Use of Resmetirom and Semaglutide as MASH-Targeted TherapyReviewIndustry & policyPaper
ADA Scientific Sessions 2025 Abstract·13 JunAssociation of the Spectrum of Dysglycemia with Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) and Hepatic FibrosisStudy in peoplePopulationsPaper